A carregar...

Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin–angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with ov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Górriz, Jose Luis, Navarro-González, Juan F, Ortiz, Alberto, Vergara, Ander, Nuñez, Julio, Jacobs-Cachá, Conxita, Martínez-Castelao, Alberto, Soler, Maria Jose
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6993197/
https://ncbi.nlm.nih.gov/pubmed/32003834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfz237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!